Are All Alginate Dressings Equivalent?

Alginate dressings are widely used in wound treatment for their healing and hemostatic properties and their capacity to drain exudate. However, a clear understanding of the heterogeneity within this class of dressings is lacking. Numerous sources of variability exist between alginate dressings: their composition (% of calcium alginate relative to other components), the ratio of D-Mannuronic and L-Guluronic acids in the alginate fraction, their purity (presence of toxic contaminants), and the shape of their fibers (surface and thickness). These parameters affect the performance and safety of alginate dressings, which may thus not be interchangeable in clinical practice. Therefore, clinicians must be aware of these differences to ensure optimal treatment and avoid complications or suboptimal healing. The objective of this study was to compare six alginate dressings to conclude or not on their equivalence. The results obtained demonstrate considerable variability between alginate dressings in the assessed characteristics: composition, Ca<sup>2+</sup> release, level of cytotoxicity, fiber shape, draining capacity, and their resistance to traction. Algostéril, the only pure calcium alginate rich in G, releases a specific dose of Ca<sup>2+</sup> and is the only non-cytotoxic dressing. With its multilobed fibers that are statistically the thickest, it provides the best draining capacity and greatest resistance to traction. These results demonstrate that alginate dressings are not equivalent. Each dressing is distinct, and consequently the clinical performance of one cannot be transposed to the others. Therefore, each alginate dressing should demonstrate its own efficacy, in a given indication, through a clinical trial.

Authors

Institutions

Publication Details

Journal
Journal of Biomedical Materials Research Part B Applied Biomaterials
Published
2025-02-20
DOI
https://doi.org/10.1002/jbm.b.35557
Citations
8
Primary Topic
Wound Healing and Treatments
Type
article
Field-Weighted Citation Impact
8.21
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Are All Alginate Dressings Equivalent?

Richard Proust, Laurence Jeanmichel, Anne‐Charlotte Ponsen, Marina Samardzic et al.
8 citations
Journal of Biomedical Materials Research Part B Applied Biomaterials
Wound Healing and Treatments
8.21
article

Are All Alginate Dressings Equivalent?

Richard Proust, Laurence Jeanmichel, Anne‐Charlotte Ponsen, Marina Samardzic, Georges Uzan, Céline Revenu, Arnaud Coudreuse, Laura Duciel, Fabio Ziarelli
article en
8 citations

Abstract

Alginate dressings are widely used in wound treatment for their healing and hemostatic properties and their capacity to drain exudate. However, a clear understanding of the heterogeneity within this class of dressings is lacking. Numerous sources of variability exist between alginate dressings: their composition (% of calcium alginate relative to other components), the ratio of D-Mannuronic and L-Guluronic acids in the alginate fraction, their purity (presence of toxic contaminants), and the shape of their fibers (surface and thickness). These parameters affect the performance and safety of alginate dressings, which may thus not be interchangeable in clinical practice. Therefore, clinicians must be aware of these differences to ensure optimal treatment and avoid complications or suboptimal healing. The objective of this study was to compare six alginate dressings to conclude or not on their equivalence. The results obtained demonstrate considerable variability between alginate dressings in the assessed characteristics: composition, Ca<sup>2+</sup> release, level of cytotoxicity, fiber shape, draining capacity, and their resistance to traction. Algostéril, the only pure calcium alginate rich in G, releases a specific dose of Ca<sup>2+</sup> and is the only non-cytotoxic dressing. With its multilobed fibers that are statistically the thickest, it provides the best draining capacity and greatest resistance to traction. These results demonstrate that alginate dressings are not equivalent. Each dressing is distinct, and consequently the clinical performance of one cannot be transposed to the others. Therefore, each alginate dressing should demonstrate its own efficacy, in a given indication, through a clinical trial.

Journal of Biomedical Materials Research Part B Applied BiomaterialsVol. 113(3)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Aix-Marseille Université (FR), Université Paris-Saclay (FR), Brothier (France) (FR), Centrale Méditerranée (FR), Hôpital Paul-Brousse (FR), Centre de Transfert de Technologie du Mans (FR), Université de Lorraine (FR)
Good health and well-being
Openalex Percentile: Top 3%
Wound Healing and Treatments
8.21
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.